Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Inherited Mindset: Firing Your Family’s Financial Beliefs 3 min · 27 Sep 2026 · The Level Up Podcast w/ Paul Alex

The Rise of the AI Moderates 32 min · 27 Sep 2026 · The AI Daily Brief: Artificial Intelligence News and Analysis

7AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

The Sunday Paper Review 27th September 31 min · 27 Sep 2026 · The Pat Kenny Show

Danielle with… Amber Glenn and Pasha Pashkov 1h 0m · 27 Sep 2026 · Pod Meets World

Khvicha Kvaratskhelia - The Football Interview 9 min · 27 Sep 2026 · Football Daily

Report any issue

Source

Recorded29 Jan 2026

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:15585406

Show notes

Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases? Credit available for this activity expires: 1/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?ecd=bdc_podcast_libsyn_mscpedu

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in